Who will leave Trump's Cabinet next?

**Stage 1 — Blind analysis (ignore market prices):**

Robert F. Kennedy Jr. (HHS Secretary) faces unusually concentrated pressure: large numbers of HHS staff publicly demanded his resignation, bipartisan lawmakers have called for removal, family members have publicly denounced him, and multiple outlets report insiders saying his tenure is nearing its end. These are high-frequency signals that a Secretary is politically vulnerable. In addition, a recorded outreach that triggered bipartisan backlash and sustained criticism of his vaccine policy decisions materially increases the political cost of keeping him in office — both for the administration’s public health credibility and for legislators whose support or silence matters to Trump’s agenda.

Countervailing signals are meaningful but not decisive. Senior administration officials (e.g., the CMS administrator) and HHS spokespeople have publicly defended the status quo, and Kennedy himself insists he will not resign. The White House has deployed him for road events ahead of the midterms, signaling they still find him useful for messaging to certain constituencies. Historically, Presidents (including Trump) have both fired close allies abruptly and retained controversial figures when they serve tactical political purposes. That mixed precedent introduces timing uncertainty: removal is plausible in the near term (weeks–months), but it could also be deferred until political payoff is exhausted or until a cleaner pretext emerges.

Weighing the concentrated domestic and bipartisan pressure, the scale of staff dissent, and multiple insider reports that explicitly say his tenure is near its end, the balance of evidence points toward RFK Jr. being the next Cabinet member to depart — likely before the end of 2026 or shortly thereafter — unless the White House elects to double down politically. I estimate an independent probability of ~55% that Kennedy will be the next Cabinet exit among the top contenders.

**Stage 2 — Market calibration (compare to current market prices):**

The current market price for "Yes" on RFK Jr. is 33%, substantially lower than my 55% independent estimate. Reasons the market might be pricing him lower:

- *Time-horizon and sequencing uncertainty:* The market spreads probability across multiple plausible leavers; participants may expect smaller scandals or personnel shifts (e.g., staffers, lesser-known officials) before a high-profile firing, or they may believe Trump will remove someone else for tactical reasons. - *Insider denials and public defenses:* Repeated, confident denials from allied officials and the fact Kennedy is being publicly used on the campaign trail create ambiguity that encourages a lower immediate-exit probability. - *Risk diversification by market actors:* Traders may be skeptical of media reports or discount them because Trump has previously resisted pressure in some cases; therefore markets price conservatively.

Why the market may be underpricing the risk (supporting my higher independent probability):

- *Concentrated, cross-cutting pressure is rare and potent.* Large internal petitions and bipartisan calls are stronger signals than routine controversies and historically correlate with Cabinet exits more often than not. - *Multiple corroborating sources.* Independent insider reports (Puck, staff petitions, family statements) pointing in the same direction increase confidence beyond a single rumor.

Recommendation for traders: the divergence between my independent 55% and market 33% suggests the market may be underestimating the probability RFK Jr. is next to go. If you agree with the weight of internal staff dissent and bipartisan backlash, buying Yes looks attractive; if you believe White House denials and continued usage on the trail indicate protection, maintain a No position.

**Comparative view versus other contenders:** I view RFK Jr. as the single most plausible next exit because the intensity and breadth of opposition to him exceed the controversies currently surrounding the other named contenders. The market’s spread across the five names seems to reflect uncertainty about sequencing rather than evidence those other figures are significantly more likely to leave imminently.